These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8554413)

  • 1. Hormonal therapy for gastrointestinal cancer.
    Lillemoe KD
    Ann Surg; 1996 Jan; 223(1):12-3. PubMed ID: 8554413
    [No Abstract]   [Full Text] [Related]  

  • 2. Progress toward hormonal therapy of gastrointestinal cancer.
    Bold RJ; Ishizuka J; Townsend CM
    Ann Surg; 1996 Jan; 223(1):4-11. PubMed ID: 8554417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of gastrointestinal hormones.
    Debas HT
    Adv Surg; 1988; 21():157-87. PubMed ID: 3318309
    [No Abstract]   [Full Text] [Related]  

  • 4. Gastro-intestinal hormones.
    Foster PN
    Practitioner; 1987 Feb; 231(1424):207-12. PubMed ID: 2891132
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical applications of gastrointestinal hormones.
    Modlin IM; Basson MD
    Endocrinol Metab Clin North Am; 1993 Dec; 22(4):823-44. PubMed ID: 8125074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings of the 5th International Conference on Neoadjuvant Hormonal Therapy for Prostate Cancer. Cambridge, Massachusetts, March 17-18, 2000.
    Mol Urol; 2000; 4(3):89-293; quiz 297-302. PubMed ID: 11184766
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evolution of endocrine therapy for prostate cancer].
    Igawa T; Saito Y
    Nihon Rinsho; 2000 Jul; 58 Suppl():176-81. PubMed ID: 11022709
    [No Abstract]   [Full Text] [Related]  

  • 8. [New approach to the treatment of gastrointestinal tract and pancreatic tumors: antrectomy and the administration of gastrointestinal tract hormones].
    Svet-Moldavskiĭ GIa; Holland JF
    Dokl Akad Nauk SSSR; 1978; 241(4):985-7. PubMed ID: 679815
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings of the 1st International Conference on Neoadjuvant Hormonal Therapy for Prostate Cancer. Boston, Massachusetts, March 29-30, 1996.
    Urology; 1997 Mar; 49(3A Suppl):1-118; quiz 121-3. PubMed ID: 9123726
    [No Abstract]   [Full Text] [Related]  

  • 10. Secondary hormonal therapy.
    Smith DC
    Semin Urol Oncol; 1997 Feb; 15(1):3-12. PubMed ID: 9050134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possible role of sexual and gastrointestinal hormones on cancer of the digestive system].
    Spiliotis J; Saint-Aubert B; Joyeux H
    Bull Cancer; 1991 Nov; 78(11):1007-11. PubMed ID: 1369546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined radiation and hormonal therapy or dose escalation for men with unfavourable-risk prostate cancer: an evidence-based approach using a synthesis of randomized clinical trials.
    Nanda A; D'Amico AV
    BJU Int; 2008 Nov; 102(10):1366-8. PubMed ID: 18778343
    [No Abstract]   [Full Text] [Related]  

  • 13. Current status of endocrine therapy for metastatic breast cancer.
    Kimmick G; Muss HB
    Oncology (Williston Park); 1995 Sep; 9(9):877-86, 889-90; discussion 892-4. PubMed ID: 8562327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings of the 3rd International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer.
    Clin Cancer Res; 2004 Jan; 10(1 Pt 2):327S-409S; quiz i-iv. PubMed ID: 14981797
    [No Abstract]   [Full Text] [Related]  

  • 15. Hormone-refractory prostate cancer: an evolving standard of care.
    Small EJ; Reese DM; Vogelzang NJ
    Semin Oncol; 1999 Oct; 26(5 Suppl 17):61-7. PubMed ID: 10604272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of gastrointestinal hormones].
    Fritsch WP
    Z Gastroenterol; 1993 Nov; 31 Suppl 5():13-4. PubMed ID: 8197792
    [No Abstract]   [Full Text] [Related]  

  • 17. [Breast cancer subtypes and their endocrine-metabolic basis; practical aspects].
    Bershteĭn LM; Semiglazov VF
    Vopr Onkol; 2011; 57(5):559-66. PubMed ID: 22238924
    [No Abstract]   [Full Text] [Related]  

  • 18. New concepts of treatment strategies for hormone-related cancer. Proceedings of the 20th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium. March 11-12, 2005. Nagoya, Japan.
    Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():1-99. PubMed ID: 16273362
    [No Abstract]   [Full Text] [Related]  

  • 19. Choice of first-line treatment for metastatic prostate cancer.
    Prescrire Int; 2013 Feb; 22(135):51. PubMed ID: 23444511
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormonal modulation in the treatment of breast cancer.
    Adelson K; Germain D; Raptis G; Biran N
    Endocrinol Metab Clin North Am; 2011 Sep; 40(3):519-32, viii. PubMed ID: 21889718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.